IDiyas

For the Inventor, By the Inventor

San Diego, CA, United States of America

Kathleen R Whitten

USPTO Granted Patents = 12

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:

goldMedal7 out of 174 
 
Agouron Pharmaceuticals, Inc.
 patents
silverMedal3 out of 1,037 
 
Japan Tobacco Inc.
 patents
bronzeMedal1 out of 1 
 
Agouron Phramaceuticals, Inc.
 patent
4. 4 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1998-2003

Loading Chart...
12 patents (USPTO):Explore Patents
1. 6605721 - Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors (2003-08-12),
2. 6512135 - Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors (2003-01-28),
3. 6465661 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-10-15),
4. 6407285 - Intermediates for making HIV-protease inhibitors and methods for making HIV-protease inhibitors (2002-06-18),
5. 6392067 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2002-05-21),
6. 6316625 - Methods of making HIV-protease inhibitors and intermediates for making HIV-protease inhibitors (2001-11-13),
7. 6303786 - Processes for making nelfinavir mesylate (2001-10-16),
8. 6117999 - Methods of making HIV-protease inhibitors and intermediates for making (2000-09-12),
9. 6084107 - Intermediates for making HIV-protease inhibitors (2000-07-04),
10. 5962725 - Intermediate compounds useful for making HIV protease inhibitors such as (1999-10-05),
11. 5925759 - Methods of making HIV-protease inhibitors and intermediates for making (1999-07-20),
12. 5705647 - Intermediates for making HIV-protease inhibitors (1998-01-06),

Title: **Kathleen R. Whitten: Pioneering Innovator in HIV Research**

Introduction

Kathleen R. Whitten, based in San Diego, CA, is an influential inventor celebrated for her significant contributions to the field of biomedical research. With a remarkable portfolio of 12 patents, her work predominantly focuses on the development of innovative HIV-protease inhibitors, which play a critical role in combating the HIV virus.

Latest Patents

Among her latest innovations, Kathleen has patented methods and intermediates for creating HIV-protease inhibitors. These inhibitors are designed to block the biological activity of the HIV protease enzyme, effectively halting the replication of the HIV virus. Her inventive compounds and methods represent a leap forward in the fight against HIV/AIDS, enabling the preparation of these vital compounds through novel techniques.

Career Highlights

Throughout her career, Kathleen has made significant strides in pharmaceutical research, particularly during her time at Agouron Pharmaceuticals, Inc. Her work in the field has not only advanced scientific understanding but has also contributed to the development of therapies that impact countless lives.

Collaborations

Kathleen has worked alongside notable colleagues, including Srinivasan Babu and Bennett C. Borer. Their collaborative efforts have helped bridge gaps in research and fostered advancements that are pivotal in the ongoing battle against HIV.

Conclusion

Kathleen R. Whitten exemplifies dedication to innovation, with her patents marking her as a leading figure in HIV research. Her groundbreaking work continues to inspire future generations of inventors and researchers aiming to make a difference in the health sector.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…